Azithromycin (ophthalmic) warnings and precautions: Difference between revisions
Created page with "__NOTOC__ {{Azithromycin}} {{CMG}} ==Warnings And Precautions== ===Topical Ophthalmic Use Only=== NOT FOR INJECTION. AzaSite is indicated for topical ophthalmic use only, a..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Azithromycin}} | {{Azithromycin (ophthalmic)}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==Warnings | ==Warnings and Precautions== | ||
===Topical Ophthalmic Use Only=== | ====Topical Ophthalmic Use Only==== | ||
NOT FOR INJECTION. AzaSite is indicated for topical ophthalmic use only, and should not be administered systemically, injected subconjunctivally, or introduced directly into the anterior chamber of the eye. | NOT FOR INJECTION. AzaSite is indicated for topical ophthalmic use only, and should not be administered systemically, injected subconjunctivally, or introduced directly into the anterior chamber of the eye. | ||
===Anaphylaxis and Hypersensitivity with Systemic Use of Azithromycin=== | ====Anaphylaxis and Hypersensitivity with Systemic Use of Azithromycin==== | ||
In patients receiving systemically administered azithromycin, serious allergic reactions, including angioedema, anaphylaxis, and dermatologic reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported rarely in patients on azithromycin therapy. Although rare, fatalities have been reported. The potential for anaphylaxis or other hypersensitivity reactions should be considered based on known hypersensitivity to azithromycin when administered systemically. | In patients receiving systemically administered azithromycin, serious allergic reactions, including [[angioedema]], [[anaphylaxis]], and dermatologic reactions including [[Stevens-Johnson syndrome]] and [[toxic epidermal necrolysis]] have been reported rarely in patients on azithromycin therapy. Although rare, fatalities have been reported. The potential for anaphylaxis or other hypersensitivity reactions should be considered based on known hypersensitivity to azithromycin when administered systemically. | ||
===Growth of Resistant Organisms with Prolonged Use=== | ====Growth of Resistant Organisms with Prolonged Use==== | ||
As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super-infection occurs, discontinue use and institute alternative therapy. Whenever clinical judgment dictates, the patient should be examined with the aid of magnification, such as slit-lamp biomicroscopy, and where appropriate, fluorescein staining. | As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super-infection occurs, discontinue use and institute alternative therapy. Whenever clinical judgment dictates, the patient should be examined with the aid of magnification, such as slit-lamp biomicroscopy, and where appropriate, fluorescein staining. | ||
===Avoidance of Contact Lenses=== | ====Avoidance of Contact Lenses==== | ||
Patients should be advised not to wear contact lenses if they have signs or symptoms of bacterial conjunctivitis.<ref>{{Cite web | last = | first =|title = | Patients should be advised not to wear contact lenses if they have signs or symptoms of bacterial [[conjunctivitis]].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = |title = AZASITE (AZITHROMYCIN) SOLUTION [INSPIRE PHARMACEUTICALS, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5dc0f75a-1e14-469f-af4f-c668a32f2328 |publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 21:47, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Warnings and Precautions
Topical Ophthalmic Use Only
NOT FOR INJECTION. AzaSite is indicated for topical ophthalmic use only, and should not be administered systemically, injected subconjunctivally, or introduced directly into the anterior chamber of the eye.
Anaphylaxis and Hypersensitivity with Systemic Use of Azithromycin
In patients receiving systemically administered azithromycin, serious allergic reactions, including angioedema, anaphylaxis, and dermatologic reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported rarely in patients on azithromycin therapy. Although rare, fatalities have been reported. The potential for anaphylaxis or other hypersensitivity reactions should be considered based on known hypersensitivity to azithromycin when administered systemically.
Growth of Resistant Organisms with Prolonged Use
As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super-infection occurs, discontinue use and institute alternative therapy. Whenever clinical judgment dictates, the patient should be examined with the aid of magnification, such as slit-lamp biomicroscopy, and where appropriate, fluorescein staining.
Avoidance of Contact Lenses
Patients should be advised not to wear contact lenses if they have signs or symptoms of bacterial conjunctivitis.[1]
References
Adapted from the FDA Package Insert.